1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,510 | 1,580 | 15.12. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.12. | Ikonisys SA: Ikonisys: Cytofast Auto: The First Fully Automatic Universal Monolayer Cytology Processor Is Born | 230 | Business Wire | Regulatory News:
Hospitex international, the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| 24.11. | Ikonisys SA: Ikonisys: Hospitex Initiates International Dialogues for Pilot Projects in Oncology Diagnostics Following ADB Delegation Visit | 351 | Business Wire | Regulatory News:
Hospitex, the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices, announces... ► Artikel lesen | |
| 07.10. | Ikonisys SA: Hospitex Wins Public Tender at Policlinico di Bari for Cytofast Cytology Systems | 231 | Business Wire | Regulatory News:
Hospitex,the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices, has been... ► Artikel lesen | |
| 30.09. | XFRA 9W8: WIEDERAUFNAHME/RESUMPTION | 132 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 01.07. | Ikonisys SA: Suspension of Trading of Shares on Euronext Growth Paris Until the Publication of the 2024 Annual Report | 316 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 01.07. | XFRA 9W8: AUSSETZUNG/SUSPENSION | 323 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 2 9W8... ► Artikel lesen | |
| 04.06. | ALIKO SCIENTIFIC (Ikonisys SA), Through Its Fully Owned Italian Subsidiary Hospitex International, Signs Exclusive Distribution Agreement for Italy with Menarini Diagnostics | 317 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) Euronext Growth: ALIKO, through its fully owned Italian subsidiary Hospitex International is pleased to announce the signing of an exclusive distribution... ► Artikel lesen | |
| 30.05. | Ikonisys SA: Ikonisys Announces a Further Postponement of the Publication of Its 2024 Annual Financial Report | 343 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 02.05. | Ikonisys SA: Ikonisys Finalized a Capital Increase Through the Offsetting of Debt | 350 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 25.04. | Ikonisys Announces the Postponement of the Publication of Its 2024 Annual Financial Report | 311 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution... ► Artikel lesen | |
| 03.04. | Ikonisys SA: Hospitex International Launches Urine24, the First-Online Urinary Cytology Test Platform, Marking a Breakthrough in Early Bladder Cancer Diagnosis in Italy | 379 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), announces that its Italian subsidiary Hospitex International has launched Urine24.com, the first online-available... ► Artikel lesen | |
| 10.03. | Ikonisys SA Wins Public Tender with F. Miulli Regional General Hospital for Pathological Anatomy | 317 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of Cytology medical devices and fully owned subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company... ► Artikel lesen | |
| 27.02. | Ikonisys SA: Ikonisys Finalized a Capital Increase Through a Private Placement | 566 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 05.02. | Ikonisys' Subsidiary Hospitex Secures a Major UN-Funded Contract for Hospital IT and Networking Systems in Ethiopia | 532 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that its subsidiary Hospitex, the Italian leader in the production of medical devices, has secured... ► Artikel lesen | |
| 27.01. | Ikonisys Secures U.S. Patent for "Automated Fluorescence Microscopy Method to Determine the Efficacy of Cancer and Hyperplasia Treatments" | 448 | Business Wire | Regulatory News:
Ikonisys Inc., a leader in advanced cell-based diagnostic solutions fully owned by ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), is proud to announce the grant... ► Artikel lesen | |
| 15.01. | Ikonisys: Hospitex Secures Major Public Tender for "Gaetano Martino" University Hospital in Messina | 331 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of medical devices and a subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that it has... ► Artikel lesen | |
| 10.01. | Ikonisys SA: Ikonisys finalized a capital increase through the offsetting of debt | 411 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 31.12.24 | Ikonisys Finalized the Acquisition of Hospitex with the Issuance of 2M New Shares to ETH Scientific | 566 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,380 | +1,74 % | Starke Kursanstiege - AJN Resources, Delivery Hero, Siemens Healthineers | Ein massiver Stellenabbau betrifft nicht nur die deutsche Wirtschaft, auch in der Schweiz sind Umstrukturierungen erforderlich, um sich den Marktgegebenheiten anzupassen. Nach der überstürzten Übernahme... ► Artikel lesen | |
| FRESENIUS | 48,500 | +1,23 % | AKTIEN IM FOKUS: Medizintechnikwerte von Exane bewegt - 'Zweigeteiltes 2026' | FRANKFURT (dpa-AFX) - Die Aktien von Siemens Healthineers und Sartorius haben am Mittwoch nach einer Studie von Exane BNP Paribas zum europäischen Medizintechniksektor unterschiedliche Richtungen eingeschlagen.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,110 | +3,87 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,970 | +0,13 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,960 | -1,59 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| BETA BIONICS | 29,720 | -0,13 % | Beta Bionics, Inc.: Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 | ||
| CARL ZEISS MEDITEC | 40,120 | +0,30 % | EQS-Adhoc: Carl Zeiss Meditec AG: Beendigung der Vorstandstätigkeit von Maximilian Foerst zum 31.12.2025 und interimistische Übernahme des Vorstandsvorsitzes durch Andreas Pecher zum 01.01.2026 | EQS-Ad-hoc: Carl Zeiss Meditec AG / Schlagwort(e): Personalie
Carl Zeiss Meditec AG: Beendigung der Vorstandstätigkeit von Maximilian Foerst zum 31.12.2025 und interimistische Übernahme... ► Artikel lesen | |
| CERIBELL | 21,900 | +4,63 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| GERRESHEIMER | 28,120 | +6,92 % | Gerresheimer AG: Strukturelle Herausforderungen bestehen weiterhin in der Branche. Kursziel gesenkt; Halten. | Gerresheimer (GXI) bleibt strukturell belastet in einem sich abschwächenden Markt für pharmazeutische Verpackungen. Schott Pharma, ein naher Wettbewerber, berichtete von einer rückläufigen Nachfrage... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 36,120 | 0,00 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| PROGYNY | 26,360 | -1,35 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,890 | -1,39 % | William Blair initiates Aveanna Healthcare stock with Outperform rating | ||
| HEARTBEAM | 2,630 | +14,35 % | Heartbeam stock is a buy, this analyst says | ||
| GENEDX | 150,62 | -0,46 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| QUIPT HOME MEDICAL | 3,500 | +34,10 % | Quipt Home Medical Corp.: Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management | Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's... ► Artikel lesen |
Das Unternehmen IKONISYS kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,72 % bei einem Aktienkurs von 1,430 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IKONISYS finden Sie auf Wallstreet Online.